Abstract
We developed a method for early diagnosis of cancers based on spectrally- and time- resolved endogenous fluorescence as a contrast factor. Promising results have already been obtained for bladder cancers. A detailed clinical study is presented.
© 2005 Optical Society of America
PDF ArticleMore Like This
K. Steenkeste, A. Deniset, S. Lévêque-Fort, M-P. Fontaine-Aupart, S. Lécart, S. Ferlicot, and P. Eschwège
ME76 Biomedical Topical Meeting (BIOMED) 2006
C. C. Yu, J. Mirkovic, C. Lau, G. O’Donoghue, S. A. McGee, A. Elackattu, G. A. Grillone, Z. Wang, E. A. Stier, R. R. Dasari, K. Badizadegan, and M. S. Feld
BWD3 Biomedical Optics (BIOMED) 2008
J. C. Y. Kah, M. C. Olivo, C. J. R. Sheppard, and W. K. O. Lau
TuD1 European Conference on Biomedical Optics (ECBO) 2005